Literature DB >> 28209697

Erika Yue Lee1, Raed Alhusayen2, Perla Lansang3, Neil Shear4, Jensen Yeung5.   

Abstract

Entities:  

Year:  2017        PMID: 28209697      PMCID: PMC5395403     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  40 in total

1.  Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.

Authors:  C O Mendonça; C E M Griffiths
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

2.  Surgical treatment of sinuses by deroofing in hidradenitis suppurativa.

Authors:  Simone van Hattem; Julia R Spoo; Barbara Horváth; Marcel F Jonkman; Fredrik W J Leeman
Journal:  Dermatol Surg       Date:  2011-12-30       Impact factor: 3.398

3.  Hidradenitis suppurativa markedly decreases quality of life and professional activity.

Authors:  Łukasz Matusiak; Andrzej Bieniek; Jacek C Szepietowski
Journal:  J Am Acad Dermatol       Date:  2010-04       Impact factor: 11.527

4.  Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study.

Authors:  Florence Canoui-Poitrine; Aurélie Le Thuaut; Jean E Revuz; Cédric Viallette; Germaine Gabison; Florence Poli; Florence Pouget; Pierre Wolkenstein; Sylvie Bastuji-Garin
Journal:  J Invest Dermatol       Date:  2012-12-13       Impact factor: 8.551

5.  A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.

Authors:  I Miller; C D Lynggaard; S Lophaven; C Zachariae; D N Dufour; G B E Jemec
Journal:  Br J Dermatol       Date:  2011-06-30       Impact factor: 9.302

Review 6.  Hidradenitis suppurativa.

Authors:  F William Danby; Lynette J Margesson
Journal:  Dermatol Clin       Date:  2010-10       Impact factor: 3.478

7.  Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.

Authors:  G Gener; F Canoui-Poitrine; J E Revuz; O Faye; F Poli; G Gabison; F Pouget; C Viallette; P Wolkenstein; S Bastuji-Garin
Journal:  Dermatology       Date:  2009-07-08       Impact factor: 5.366

Review 8.  γ-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis.

Authors:  Andrew E Pink; Michael A Simpson; Nemesha Desai; Richard C Trembath; Jonathan N W Barker
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

9.  Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.

Authors:  Alexa B Kimball; Francisco Kerdel; David Adams; Ulrich Mrowietz; Joel M Gelfand; Robert Gniadecki; Errol P Prens; Joel Schlessinger; Christos C Zouboulis; Hessel H van der Zee; Marie Rosenfeld; Parvez Mulani; Yihua Gu; Susan Paulson; Martin Okun; Gregor B E Jemec
Journal:  Ann Intern Med       Date:  2012-12-18       Impact factor: 25.391

10.  Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.

Authors:  G B Jemec; P Wendelboe
Journal:  J Am Acad Dermatol       Date:  1998-12       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.